Journals / Toraks Dergisi / 2005 / Cilt: 6 - Sayı: 1

Plasma D-dimer levels in patients with active pulmonary tuberculosis

Aktif akciğer tüberkülozlu olgularda plazma D-dimer düzeyi

Pages
57–61
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that the levels of plasma D-dimer in patients with active pulmonary tuberculosis were significantly higher than that of healthy persons, but no significant differences were found between the patients with pulmonary tuberculosis and patients with lung diseases other than tuberculosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In patients with active pulmonary tuberculosis, hypercoagulability due to inflammation and hemostatic changes by cytokines is reported.
📊
Key Findings & Data:Increase in plasma levels of D-dimer, a product of fibrin degradation, can be expected in this group.
💡
Conclusion & Impact:The results showed that the levels of plasma D-dimer in patients with active pulmonary tuberculosis were significantly higher than that of healthy persons, but no significant differences were found between the patients with pulmonary tuberculosis and patients with lung diseases other than tuberculosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tüberküloz · pulmoner · Trombofili

Abstract

In patients with active pulmonary tuberculosis, hypercoagulability due to inflammation and hemostatic changes by cytokines is reported. Increase in plasma levels of D-dimer, a product of fibrin degradation, can be expected in this group. For this aim, plasma D-dimer levels were prospectively evaluated in patients with active pulmonary tuberculosis. The levels of plasma D-dimer were measured by quantitative latex method in 45 patients with pulmonary tuberculosis (Group 1), in 39 patients with lung disease other than tuberculosis (Group 2), and in 19 healthy persons (Group 3). The mean plasma D-dimer concentrations were 687.58±1060.64 µg/L in Group 1, 1095.51 ±1378.82 µg/L in Group 2 and 31.95±22.55 µg/L in Group 3. The mean plasma D-dimer concentrations of Group 1 and Group 2 were found significantly higher than the concentrations of Group 3 (p=0.001, p=0.001). No statistical difference was found between the plasma D-dimer concentrations of Group 1 and 2 (p=0.127). The results showed that the levels of plasma D-dimer in patients with active pulmonary tuberculosis were significantly higher than that of healthy persons, but no significant differences were found between the patients with pulmonary tuberculosis and patients with lung diseases other than tuberculosis.

Özet

Aktif akciğer tüberkülozlu hastalarda sitokinlere bağlı inflamasyon ve hemostatik değişiklikler sonucu hiperkoagülabilite geliştiği bildirilmektedir. Buna bağlı olarak bir fibrin yıkım ürünü olan plazma D-dimer düzeyinde yükselme beklenebilir. Bu amaçla, aktif akciğer tüberkülozlu olgularda plazma D-dimer düzeyi prospektif olarak araştırıldı. Akciğer tüberkülozlu (Grup 1) 45, tüberküloz dışında akciğer hastalığı bulunan (Grup 2) 39 ve sağlıklı (Grup 3) 19 olguda kantitatif lateks yöntemiyle plazma D-dimer düzeyi ölçüldü. Plazma D-dimer konsantrasyonları ortalamaları, Grup 1’de 687.58±1060.64 µg/L, Grup 2’de 1095.51±1378.82 µg/L, Grup 3’te ise 31.95±22.55 µg/L olarak bulundu. Grup 1 ve 2’nin ortalama plazma D-dimer düzeyi, Grup 3’teki olgulardakinden istatistiksel olarak anlamlı düzeyde yüksek bulundu (p=0.001, p=0.001). Grup 1 ve 2 arasında ise ortalama plazma D-dimer düzeyi yönünden anlamlı fark bulunmadı (p=0.127). Sonuç olarak, akciğer tüberkülozlu olgularda plazma D-dimer düzeyinin sağlıklı kişilerdekine oranla istatistiksel olarak anlamlı oranda yükseldiği, fakat tüberküloz dışındaki akciğer hastalıklarındaki D-dimer yükselişi ile anlamlı fark göstermediği saptandı.

🔖

Cite This Article

ATAÇ, G., GÜNGÖR, G., AKSOY, E., TAKIR, H. B., BÖLÜKBAŞI, Y., CAN, G. (2005). Plasma D-dimer levels in patients with active pulmonary tuberculosis. Toraks Dergisi, Cilt: 6 - Sayı: 1, 57–61. https://ajindex.com/articles/368170

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Iseman MD. Klinisyenler için tüberküloz kılavuzu: immünite ve patogenez (çev: Özkara fi). İstanbul: Nobel Matbaacılık; 2002:63-91
  2. Robson SC, White NW, Aronson I et al. Acute-phase response and the hypercoagulable state in pulmonary tuberculosis. Br J Haematol 1996; 93:943-9
  3. White NW. Venous thrombosis and rifampicin. Lancet 1989;2:434-5
  4. Cowie RL, Dansey RD, Hay M. Deep-vein thrombosis and pulmonary tuberculosis (Letter). Lancet 1989;2:1397
  5. Turken O, Kunter E, Sezer M et al. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002;6:927-32
  6. Gunther A, Mosavi P, Heinemann S et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Am J Respir Crit Care Med 2000;161:454-62
  7. Castro DJ, Perez-Rodriguez E, Montaner L et al. Diagnostic value of D dimer in pulmonary embolism and pneumonia. Respiration 2001;68:371-5
  8. Cordova C, Musca A, Violi F et al. Platelet hyperfunction in patients with chronic airways obstruction. Eur J Respir Dis 1985;66:9-12
  9. Rostagno C, Prisco D, Boddi M, Poggesi L. Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hyper-tension secondary to chronic obstructive disease. Eur Respir J 1991;4:147-51
  10. Ferrigno D, Buccheri G, Ricca I. Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J 2001;17:667-73
  11. Roselli M, Mineo TC, Basili S et al. Vascular endothelial growth factor (VEGF-A) plasma levels in nonsmall cell lung cancer:relationship with coagulation and platelet activation markers. Thromb Haemost 2003;89:177-84
  12. Taguchi O, Gabazza EC, Yasui H et al. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax 1997;52:563-5
  13. Goble M, Iseman MD, Madsen LA et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniasid and rifampin. N Engl J Med 1993;328:527-32
  14. Buccheri G, Torchio P, Ferrigno D. Plasma levels of D-dimer in lung carcinoma. Cancer 2003;97:3044-52
  15. Seitz R, Rappe N, Kraus M et al. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis. Blood Coagul Fibrinolysis 1993;2:249-54
  16. Kelly J, Rudd A, Lewis RR, Hunt BJ. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med 2002;162:747-56
  17. Brotman DJ, Segal BJ, Jani JT et al. Limitations of D-dimer testing in unselected inpatients with suspected venous th